Key Drivers
- Strong returns
- Cash softness
- Leverage risk
AIAI Summary
OPCH is no longer a steady healthcare compounder but a prove-it name after the revenue miss and FY2026 cut, so the stock now hinges on near-term proof that chronic volumes, reimbursement mix, and quarterly cash flow can stabilize before the 19.50 support breaks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong returns
- •Cash softness
- •Leverage risk
OPCH is profitable and cash-generative on a full-year basis, but high leverage, heavy intangibles, and a weak latest-quarter cash flow profile temper the outlook.
Price Behavior
Key Price Behavior Insights:
- •Breakdown gap
- •Failed rebound
- •Near support
OPCH remains technically weak and bearish after a sharp late-April breakdown, with rallies failing below $20.50-$21.30 and $19.50 now acting as near-term support.
Sharp drop from $26.87 to $20.33 on 2026-04-30 signaled a breakdown
Sentiment & News
Key News Insights:
- •Revenue miss
- •Guidance reset
- •Legal scrutiny
Option Care Health posted a slight EPS beat but missed revenue, cut FY2026 guidance, and saw shares plunge as securities-law investigations rapidly multiplied over the revenue shortfall and outlook reset.
The headlines are negative for OPCH and likely to keep sentiment and valuation under pressure until visibility improves
Similar Companies in Healthcare
Other companies in the same sector with AI ratings